Profile data is unavailable for this security.
About the company
Solara Active Pharma Sciences Limited is an India-based company manufacturing and supplying commercial active pharmaceutical ingredients (APIs) across various therapeutic categories. It operates through the single segment, Manufacture and sale of Active Pharma Ingredients. Its Commercial product category includes Albendazole, Aprepitant (Antiemetic), Buspirone, Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, and Zileuton. Its research and development (R&D) products include Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, and Tranexamic Acid. The Company's subsidiaries include Shasun USA Inc., Sequent Penems Private Limited, and Solara Active Pharma Sciences Ltd. It has one R&D center in Chennai and six manufacturing sites in Ambernath, Mysuru, Mangalore, Puducherry, Cuddalore, and Vizag.
- Revenue in INR (TTM)12.22bn
- Net income in INR-5.36bn
- Incorporated2017
- Employees2.16k
- LocationSolara Active Pharma Sciences Ltd3rd & 4th Floor, Batra CentreNo.28, Sardar Patel Road, GuindyCHENNAI 600032IndiaIND
- Phone+91 4 443446700
- Fax+91 4 422350278
- Websitehttps://solara.co.in/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Themis Medicare Ltd | 4.20bn | 529.90m | 25.46bn | 1.54k | 48.09 | 6.18 | 39.78 | 6.06 | 5.75 | 5.75 | 45.63 | 44.76 | 0.7306 | 2.39 | 2.22 | 2,727,670.00 | 9.21 | 11.12 | 12.57 | 16.46 | 64.64 | 60.32 | 12.61 | 14.96 | 1.56 | -- | 0.1651 | 7.59 | 7.74 | 15.75 | -23.51 | -- | 26.73 | -- |
| Indoco Remedies Ltd | 17.73bn | 320.40m | 28.37bn | 5.93k | 92.29 | 2.60 | 20.82 | 1.60 | 3.34 | 3.34 | 175.26 | 118.23 | 0.8194 | 1.52 | 4.51 | 2,989,727.00 | 1.36 | 6.88 | 1.99 | 9.85 | 68.34 | 65.59 | 1.66 | 6.93 | 0.8142 | 1.71 | 0.4339 | 14.02 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Dishman Carbogen Amcis Ltd | 24.16bn | -2.48bn | 29.71bn | 1.13k | -- | -- | 172.03 | 1.23 | -15.81 | -15.81 | 154.06 | -- | -- | -- | -- | 21,344,260.00 | -- | -0.3986 | -- | -0.4888 | 79.30 | 73.83 | -10.27 | -1.54 | -- | -0.7216 | -- | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
| RPG Life Sciences Limited | 6.00bn | 923.20m | 41.14bn | 1.27k | 44.56 | -- | 37.24 | 6.86 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 42.42bn | 1.23k | -- | 134.16 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Solara Active Pharma Sciences Ltd | 12.22bn | -5.36bn | 44.30bn | 2.16k | -- | 2.65 | -- | 3.63 | -137.13 | -137.13 | 320.29 | 301.63 | 0.4731 | 1.77 | 2.69 | 5,667,023.00 | -20.76 | -2.44 | -36.40 | -3.84 | 38.70 | 41.16 | -43.89 | -4.49 | 0.448 | -1.30 | 0.4355 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| Aarti Drugs Ltd | 23.80bn | 1.52bn | 44.72bn | 1.06k | 29.48 | 3.50 | 21.75 | 1.88 | 16.62 | 16.62 | 259.74 | 139.96 | 0.9954 | 3.16 | 3.43 | 22,364,630.00 | 6.37 | 9.73 | 9.62 | 15.78 | 34.60 | 22.23 | 6.40 | 8.25 | 1.01 | 6.83 | 0.3159 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Morepen Laboratories Ltd | 17.45bn | 1.18bn | 45.67bn | 1.62k | 36.07 | -- | 30.52 | 2.62 | 2.31 | 2.31 | 34.26 | -- | -- | -- | -- | 10,749,300.00 | -- | 7.90 | -- | 13.34 | 37.86 | 33.34 | 6.77 | 5.49 | -- | 33.34 | -- | 0.00 | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| Hikal Ltd | 18.03bn | 677.82m | 47.71bn | 2.06k | 70.43 | -- | 25.18 | 2.65 | 5.49 | 5.49 | 145.97 | -- | -- | -- | -- | 8,749,879.00 | -- | 5.07 | -- | 7.51 | 53.06 | 46.78 | 3.76 | 5.86 | -- | 2.45 | -- | 12.19 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Gufic BioSciences Ltd | 8.14bn | 863.69m | 48.68bn | 1.45k | 55.81 | -- | 47.05 | 5.98 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| Supriya Lifescience Ltd | 6.25bn | 1.58bn | 52.18bn | 448.00 | 33.18 | 5.76 | 29.85 | 8.35 | 19.54 | 19.54 | 77.55 | 112.56 | 0.6737 | 2.01 | 6.56 | 13,950,510.00 | 16.98 | 19.08 | 18.38 | 24.04 | 66.81 | 57.12 | 25.20 | 24.71 | 4.05 | 111.46 | 0.006 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| SeQuent Scientific Ltd | 14.27bn | 54.87m | 53.14bn | 1.20k | 997.47 | -- | 68.41 | 3.72 | 0.2137 | 0.2137 | 57.18 | -- | -- | -- | -- | 11,939,190.00 | -- | 1.09 | -- | 1.76 | 45.38 | 41.97 | 0.9902 | 1.18 | -- | 0.9009 | -- | 35.06 | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Innova Captab Ltd | 11.42bn | 1.06bn | 54.45bn | -- | 40.16 | -- | 43.83 | 4.77 | 23.69 | 23.69 | 236.62 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 33.38 | 25.18 | 9.30 | 8.04 | -- | 8.89 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Aarti Pharmalabs Ltd | 19.68bn | 2.28bn | 59.70bn | 1.63k | 26.18 | 3.22 | 19.44 | 3.03 | 25.16 | 25.16 | 217.12 | 204.88 | 0.7733 | 1.62 | 4.59 | 12,095,750.00 | 8.96 | -- | 11.86 | -- | 45.56 | -- | 11.59 | -- | 0.9611 | 17.12 | 0.1723 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
Data as of Nov 11 2024. Currency figures normalised to Solara Active Pharma Sciences Ltd's reporting currency: Indian Rupee INR
11.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Sentier Investors (Singapore)as of 31 Jul 2024 | 2.13m | 4.45% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2023 | 1.23m | 2.57% |
| Think Investments LPas of 30 Sep 2023 | 875.44k | 1.82% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Oct 2024 | 615.00k | 1.28% |
| Route One Investment Co. LPas of 30 Sep 2023 | 521.31k | 1.09% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 165.06k | 0.34% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 134.97k | 0.28% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 12.72k | 0.03% |
| DFA Australia Ltd.as of 30 Sep 2024 | 2.42k | 0.01% |
| Motilal Oswal Asset Management Co. Ltd.as of 30 Sep 2024 | 441.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
